Zobrazeno 1 - 10
of 99
pro vyhledávání: '"Andrew P Stein"'
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 12, Iss 11, Pp 1653-1665 (2023)
Abstract Sabatolimab is a novel immunotherapy with immuno‐myeloid activity that targets T‐cell immunoglobulin domain and mucin domain‐3 (TIM‐3) on immune cells and leukemic blasts. It is being evaluated for the treatment of myeloid malignanci
Externí odkaz:
https://doaj.org/article/b3c448f399bf45c38812f5dfd2cc1e41
Autor:
Andrew P. Stein, Jonathan Harder, Henry R. Holmes, C. Noel Bairey Merz, Carl J. Pepine, Ellen C. Keeley
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 4 (2024)
Coronary microvascular dysfunction is an underdiagnosed pathologic process that is associated with adverse clinical outcomes. There are data to suggest that coronary microvascular dysfunction, in some cases, may be genetically determined. We present
Externí odkaz:
https://doaj.org/article/9877364d0a034024a3b7d25185124097
Publikováno v:
JAAD Case Reports, Vol 23, Iss , Pp 103-105 (2022)
Externí odkaz:
https://doaj.org/article/957ae6a068a344988fd70d9b9e53c52a
Autor:
Andrew J. Neevel, Joshua D. Smith MD, Robert J. Morrison MD, Norman D. Hogikyan MD, Robbi A. Kupfer MD, Andrew P. Stein MD
Publikováno v:
OTO Open, Vol 5 (2021)
Objective Patients with COVID-19 are at risk for laryngeal injury and dysfunction secondary to respiratory failure, prolonged intubation, and other unique facets of this illness. Our goal is to report clinical features and treatment for patients pres
Externí odkaz:
https://doaj.org/article/2e2bb62c75f64b07ad9448c81c5af059
Autor:
Andrew M. Stein, Stephan A. Grupp, John E. Levine, Theodore W. Laetsch, Michael A. Pulsipher, Michael W. Boyer, Keith J. August, Bruce L. Levine, Lori Tomassian, Sweta Shah, Mimi Leung, Pai‐Hsi Huang, Rakesh Awasthi, Karen Thudium Mueller, Patricia A. Wood, Carl H. June
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 8, Iss 5, Pp 285-295 (2019)
Tisagenlecleucel is a chimeric antigen receptor–T cell therapy that facilitates the killing of CD19+ B cells. A model was developed for the kinetics of tisagenlecleucel and the impact of therapies for treating cytokine release syndrome (tocilizumab
Externí odkaz:
https://doaj.org/article/e1eac9e64fa4445bbb240eabb2a86beb
Publikováno v:
Otolaryngology Case Reports, Vol 9, Iss , Pp 11-14 (2018)
Objective: To describe a rare presentation of acute lymphoblastic leukemia (ALL) that is important to the field of pediatric otolaryngology. Methods: The case of a nine-year old female who presented with left periorbital edema as her initial symptom
Externí odkaz:
https://doaj.org/article/acd2f913cb2849da917b064fcc8f0286
Publikováno v:
Chest. 162:e117-e121
Publikováno v:
Orthopedic Reviews (2019)
Introduction: Aberrant positioning of the ulnar nerve volar to the transverse carpal ligament is a rare anatomic variation. Case Presentation: We present the case of a 55-year-old female with unique ulnar nerve anatomy that was discovered introperati
Externí odkaz:
https://doaj.org/article/fe48538203af481c8360973ff56651dd
Publikováno v:
Global Ecology and Conservation, Vol 18, Iss , Pp - (2019)
Human-carnivore conflict is a leading cause of large carnivore declines and minimizing these conflicts is vital to maintaining viable carnivore populations. Often, however, conservation agencies and governments do not have a proper understanding of c
Externí odkaz:
https://doaj.org/article/b1ecafc4a6a54e7ca58563c2962fd53e
Autor:
Florian J. Weise, Helmut Hauptmeier, Ken J. Stratford, Matthew W. Hayward, Konstantin Aal, Marcus Heuer, Mathata Tomeletso, Volker Wulf, Michael J. Somers, Andrew B. Stein
Publikováno v:
Frontiers in Ecology and Evolution, Vol 6 (2019)
Across Africa, lions (Panthera leo) are heavily persecuted in anthropogenic landscapes. Trans-disciplinary research and virtual boundaries (geofences) programmed into GPS-tracking transmitters offer new opportunities to improve coexistence. During a
Externí odkaz:
https://doaj.org/article/ea2044d4b5354b878e2f9581600f0f22